Jenburkt Pharma - Quaterly Results

28 Jan 2025 Evaluate
With no major difference for the quarter endedDecember 2024 , the total revenue stood at Rs. 368.93  millions.Modest increase of 20.45% in the Net Profit was reported from. 54.03 millions to Rs. 65.08  millions.Operating profit for the quarter ended December 2024 rose to 104.03 millions as compared to 85.39 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 368.93 356.60 3.46 1106.45 1031.24 7.29 1419.66 1367.49 3.82
Other Income 15.82 13.46 17.53 48.41 34.79 39.15 46.67 51.23 -8.90
PBIDT 104.03 85.39 21.83 343.76 267.43 28.54 377.85 354.90 6.47
Interest 1.10 0.70 57.14 3.41 2.13 60.09 2.71 3.67 -26.16
PBDT 102.93 84.69 21.54 340.35 265.30 28.29 375.14 351.23 6.81
Depreciation 7.79 6.30 23.65 19.37 17.21 12.55 23.40 22.59 3.59
PBT 95.14 78.39 21.37 320.98 248.09 29.38 351.74 328.64 7.03
TAX 30.06 24.36 23.40 85.73 67.15 27.67 91.98 82.58 11.38
Deferred Tax 0.06 -0.64 -109.38 0.73 -3.53 -120.68 -5.21 -2.25 131.56
PAT 65.08 54.03 20.45 235.25 180.94 30.02 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 28.20 23.95 17.76 31.07 25.93 19.80 26.62 25.95 2.55

Jenburkt Pharma Share Price

1011.70 -3.15 (-0.31%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...